search
Back to results

Fat Graft Myringoplasty With and Without Platelet Rich Plasma (PRP) for Treating Smaller Tympanic Membrane Perforations

Primary Purpose

Tympanic Membrane Perforation

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Fat graft with Platelet Rich Plasma
Sponsored by
Nova Scotia Health Authority
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tympanic Membrane Perforation

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Tympanic membrane perforation measuring <50% of the area of the membrane
  • Perforation present for at least 6 months (based on history or direct observation)
  • All edges of perforation are visible

Exclusion Criteria:

  • Active ear infection at the time of the procedure
  • cholesteatoma present
  • Patients on immunosuppressive therapy (including oral steroids) or chemotherapy
  • Patients with previous failed attempt at perforation repair

Sites / Locations

  • Providence Health St Paul's Hospital
  • ENT department, Victoria General Hospital
  • Derriford Hospital
  • University Hospital North Staffordshire

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Fat graft without Platelet Rich Plasma

Fat graft with Platelet Rich Plasma

Arm Description

Step 1. Under Local Anaesthetic (or General Anaesthetic if the patient is unable to tolerate this), a fat graft is taken from just behind the mastoid process, or more posteriorly just beneath the hairline if necessary. The graft is kept moist in 0.9% saline.The ear canal is injected with local anaesthetic and the edges of the perforation are freshened. Gelfoam is placed into the middle ear and the fat graft placed on top of this until it touches the underside of the TM and slightly bulges through. In an attempt to achieve standardisation of surgical technique between sites, surgeons will be provided with an operative video to watch beforehand. Step 2. The fat graft will simply be covered with a piece of saline-soaked Gelfoam cut to completely cover the perforation and graft.

Procedure as for as for Fat graft without PRP, but at Step 2 the Gelfoam will instead be soaked in PRP derived from the patient's own whole blood. The generation of PRP is descibed below: - 10-20 mL of autologous blood collected from an antecubital vein is placed in an adenosine citrate dextrose-acid (ACD-A) collection tube to prevent premature activation Blood immediately placed in the centrifuge at 1100g for 10 minutes (once) Supernatant removed and collected into syringe Injected onto surface of fat graft Rest added to piece of gelfoam Place gelfoam + PRP on the TM perforation

Outcomes

Primary Outcome Measures

Presence or absence of tympanic membrane perforation

Secondary Outcome Measures

Degree of perforation closure
4 Groups: Total, almost complete (very small residual perforation), substantial (>50% closure), partial (<50% closure)
Infection rate
Infection measured by presence of mucopurulent discharge from operated ear
Discomfort on using vinegar drops

Full Information

First Posted
October 7, 2013
Last Updated
October 8, 2013
Sponsor
Nova Scotia Health Authority
search

1. Study Identification

Unique Protocol Identification Number
NCT01958749
Brief Title
Fat Graft Myringoplasty With and Without Platelet Rich Plasma (PRP) for Treating Smaller Tympanic Membrane Perforations
Official Title
Efficacy of Fat Graft Myringoplasty Versus Fat Plus Platelet Rich Plasma (PRP) Myringoplasty in Closing Smaller Tympanic Membrane Perforations in an Outpatient Setting: a Randomized Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Unknown status
Study Start Date
undefined (undefined)
Primary Completion Date
December 2015 (Anticipated)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nova Scotia Health Authority

4. Oversight

5. Study Description

Brief Summary
The current standard treatment for chronic tympanic membrane perforations (TMP) involves having fat grafted from the patient and inserted into the ear, through the perforation, to promote healing using the fat graft myringoplasty (FGM) technique. Platelet rich plasma (PRP) has also been used to promote TMP healing and involves having the patient provide a blood sample, which is processed to produce PRP and applied to the perforation. This prospective, multi-centre study will evaluate whether combining both these techniques can improve the rate of closure in patients with chronic TMP involving <50% of the membrane. Patients will be randomized to receive either the standard FGM treatment or FGM treatment with the addition of PRP. At 3 months postintervention a blinded observer will rate the degree of TMP closure. Differences in closure rates between the 2 groups will be compared.
Detailed Description
This will be a multi-centre, single-blinded, randomised control trial. Patients will be randomised at each site to undergo FGM with or without PRP. Step 1 in both groups is the same. Under LA (or GA if the patient is unable to tolerate this), a fat graft is taken from just behind the mastoid process, or more posteriorly just beneath the hairline if necessary. The graft is kept moist in 0.9% saline.The ear canal is injected with LA and the edges of the perforation are freshened. Gelfoam is placed into the middle ear and the fat graft placed on top of this until it touches the underside of the TM and slightly bulges through. In an attempt to achieve standardisation of surgical technique between sites, surgeons will be provided with an operative video to watch beforehand. Step 2. The surgeon is informed of the randomisation outcome into Group 1 or 2. Group 1 (Non PRP): patients will have FGM alone, and this will simply be covered with a piece of saline-soaked Gelfoam cut to completely cover the perforation and graft. Group 2 (PRP): as for Group 1, but the Gelfoam will instead be soaked in PRP derived from the patient's own whole blood. The generation of PRP is descibed below: - 10-20 mL of autologous blood collected from an antecubital vein is placed in an adenosine citrate dextrose-acid (ACD-A) collection tube to prevent premature activation Blood immediately placed in the centrifuge at 1100g for 10 minutes (once) Supernatant removed and collected into syringe Injected onto surface of fat graft Rest added to piece of gelfoam Place gelfoam + PRP on the TM perforation Post op care: patients will be asked to keep their ear dry, and cover it with a cotton ball when taking a shower or bathing for the first week, but otherwise to leave it open. They will be given an eye dropper, and instructed to use 2 drops of white vinegar in the ear three times a day for 10 days, with the head tilted over to allow the vinegar to reach the fat graft. Vinegar drops are an effective treatment for Pseudomonas infection, the most common infection in the external ear canal, and are commonly used in external ear infections. If this causes any discomfort, the patients will be instructed to stop this, and this information will be recorded at first follow up. If there is infected discharge, the patient will be instructed to contact the surgeon, and will be treated with ciprofloxacin-containing eardrops for one week. The occurrence of such an event will be recorded, but will not be a censoring event for the purposes of the study. Follow up schedule: Patients will be followed at 2 weeks, 6 weeks and 3 months post surgery. A planned interim analysis will be performed at the half-way point of the study; each centre will be compared for heterogeneity with the other sites using ANOVA, for both group 1 and group 2. Data from sites with heterogeneous data may be discarded, and/or other sites recruited, and/or existing site enrollments increased as needed to allow adequate patient recruitment. Our primary outcome measure will be tested with an unpaired t-test between the two groups. The investigators will also perform secondary analyses of the degree of closure in the non-complete closure populations between the two treatment arms using Wilcoxon non-parametric testing Power analysis: the investigators have deemed a 30% difference in closure rate between the two groups as clinically significant. The investigators estimate the closure rate for the fat alone to be 50%, based on previous publications. To show a difference of closure rate of 70% in the blood treated group, with a power of 0.8 and an alpha error of 0.05 would require 45 subjects in each group. This is for a binary outcome of pass fail. The investigators anticipate some drop out, because of failure of follow up, in the order of 30% at 3 months, and so aim to recruit 46 subjects in each arm.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tympanic Membrane Perforation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
92 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Fat graft without Platelet Rich Plasma
Arm Type
No Intervention
Arm Description
Step 1. Under Local Anaesthetic (or General Anaesthetic if the patient is unable to tolerate this), a fat graft is taken from just behind the mastoid process, or more posteriorly just beneath the hairline if necessary. The graft is kept moist in 0.9% saline.The ear canal is injected with local anaesthetic and the edges of the perforation are freshened. Gelfoam is placed into the middle ear and the fat graft placed on top of this until it touches the underside of the TM and slightly bulges through. In an attempt to achieve standardisation of surgical technique between sites, surgeons will be provided with an operative video to watch beforehand. Step 2. The fat graft will simply be covered with a piece of saline-soaked Gelfoam cut to completely cover the perforation and graft.
Arm Title
Fat graft with Platelet Rich Plasma
Arm Type
Experimental
Arm Description
Procedure as for as for Fat graft without PRP, but at Step 2 the Gelfoam will instead be soaked in PRP derived from the patient's own whole blood. The generation of PRP is descibed below: - 10-20 mL of autologous blood collected from an antecubital vein is placed in an adenosine citrate dextrose-acid (ACD-A) collection tube to prevent premature activation Blood immediately placed in the centrifuge at 1100g for 10 minutes (once) Supernatant removed and collected into syringe Injected onto surface of fat graft Rest added to piece of gelfoam Place gelfoam + PRP on the TM perforation
Intervention Type
Procedure
Intervention Name(s)
Fat graft with Platelet Rich Plasma
Primary Outcome Measure Information:
Title
Presence or absence of tympanic membrane perforation
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Degree of perforation closure
Description
4 Groups: Total, almost complete (very small residual perforation), substantial (>50% closure), partial (<50% closure)
Time Frame
3 months
Title
Infection rate
Description
Infection measured by presence of mucopurulent discharge from operated ear
Time Frame
3 months
Title
Discomfort on using vinegar drops
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Tympanic membrane perforation measuring <50% of the area of the membrane Perforation present for at least 6 months (based on history or direct observation) All edges of perforation are visible Exclusion Criteria: Active ear infection at the time of the procedure cholesteatoma present Patients on immunosuppressive therapy (including oral steroids) or chemotherapy Patients with previous failed attempt at perforation repair
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Manohar Bance, MD
Phone
902-473-5955
Email
m.bance@dal.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Manohar Bance, MD
Organizational Affiliation
Capital Health, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Providence Health St Paul's Hospital
City
Vancouver
State/Province
British Columbia
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brian Westerberg, MD
Facility Name
ENT department, Victoria General Hospital
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2Y9
Country
Canada
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Manohar Bance, MD
First Name & Middle Initial & Last Name & Degree
James Rainsbury, BMBS FRCS
Facility Name
Derriford Hospital
City
Plymouth
State/Province
Devon
Country
United Kingdom
Facility Contact:
First Name & Middle Initial & Last Name & Degree
James Rainsbury, BMBS FRCS
Facility Name
University Hospital North Staffordshire
City
Stoke-on-Trent
Country
United Kingdom
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sanjiv Kumar, FRCS

12. IPD Sharing Statement

Learn more about this trial

Fat Graft Myringoplasty With and Without Platelet Rich Plasma (PRP) for Treating Smaller Tympanic Membrane Perforations

We'll reach out to this number within 24 hrs